Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,712,859
in 10 filings, $1.0M under 10b5-1 plans

Net −$1,712,859. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-11-01 Hansen Gwenn Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) −400 68,266
2021-10-27 Ring Christine General Counsel Option exercise +800 $1.86 $1K 2,086
2021-10-27 Ring Christine General Counsel Sale −800 $35.25 $28K 1,286
2021-10-27 Ring Christine General Counsel Option exercise · Employee Stock Option (right to buy) −800 103,666
2021-10-27 Hansen Gwenn Chief Scientific Officer Option exercise +400 $7.26 $3K 14,597
2021-10-27 Hansen Gwenn Chief Scientific Officer Sale −400 $35.00 $14K 14,197
2021-10-27 Hansen Gwenn Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) −400 68,666
2021-10-11 Ring Christine General Counsel Option exercise +1,200 $1.86 $2K 2,486
2021-10-11 Ring Christine General Counsel Sale −1,200 $27.36 $33K 1,286
2021-10-11 Ring Christine General Counsel Option exercise · Employee Stock Option (right to buy) −1,200 104,466
2021-10-01 Hansen Gwenn Chief Scientific Officer Option exercise +400 $7.26 $3K 14,597
2021-10-01 Hansen Gwenn Chief Scientific Officer Sale −400 $29.92 $12K 14,197
2021-10-01 Hansen Gwenn Chief Scientific Officer Option exercise · Employee Stock Option (right to buy) −400 69,066
2021-10-01 Reinsdorf Judith A Director Grant or award · Director Stock Option (right to buy) +35,000 35,000
2021-10-01 Silva Paul M Director Grant or award · Director Stock Option (right to buy) +35,000 35,000
2021-09-10 Ring Christine General Counsel Option exercise +2,000 $1.86 $4K 3,286
2021-09-10 Ring Christine General Counsel Sale −700 $35.10 $25K 2,586
2021-09-10 Ring Christine General Counsel Sale −500 $35.77 $18K 2,086
2021-09-10 Ring Christine General Counsel Sale −800 $36.76 $29K 1,286
2021-09-10 Ring Christine General Counsel Option exercise · Employee Stock Option (right to buy) −2,000 105,666

Page 31 of 32 · 632 trades